| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
1996-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c46003509d744331887a0dfad10af1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0602107955ae81ae513c1d0a723d407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a1125e2b2f7942ff9aede3b8f7fef79 |
| publicationDate |
1997-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0758656-A3 |
| titleOfInvention |
Immunoglobulins activated by mixing with a component of histamine |
| abstract |
This invention offers activated immunoglobulin which is useful as eosinophilia-suppressing agent, immunomodulating agent, therapeutic agent for autoimmune diseases, antiinflammatory agent and antiallergic agent. The present invention further relates to a method of giving new pharmacological activity which is not inherently available in immunoglobulin of natural type to immunoglobulin; to activated immunoglobulin obtained by said method; and to a pharmaceutical composition containing said activated immunoglobulin as an effective component. |
| priorityDate |
1995-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |